Dingcong, Reymund C.
HRN: 22-45-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2023
COTRIMOXAZOLE 960MG (TAB)
01/06/2023
01/21/2023
PO
2 Tabs
Tid
Pneumocystis Jiroveci Infection, Immunocompromised State, Hiv Infection
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes